BSX vs MDT
Boston Scientific (BSX) and Medtronic (MDT) compared side by side. Medtronic (MDT) is larger, with a market cap of $122.0B versus $66.2B for Boston Scientific, about 1.8 times the size. On trailing earnings, BSX is cheaper at 18.5x versus 23.4x for MDT.
Head to head
| Metric | BSX | MDT |
|---|---|---|
| Market cap | $66.2B | $122.0B |
| P/E (TTM) | 18.5x | 23.4x |
| Forward P/E | 13.5x | 14.9x |
| Revenue (TTM) | $21.0B | $37.5B |
| Revenue growth | 7.5% | 13.7% |
| Gross margin | 69.2% | 65.3% |
| Operating margin | 22.9% | 19.3% |
| Free cash flow | $1.8B | $6.1B |
| Dividend yield | None | 3.02% |
| 1-year return | -55.4% | +4.6% |
| 5-year return (annual) | +0.4% | -1.9% |
| Max drawdown | -89% | -73% |
| FI Handbook grade | C+ | B- |
Highlighted: the stronger figure on metrics where higher or lower is clearly better.
Growth of $10,000 (5 years, price only)
BSX vs MDT FAQ
Which is bigger, BSX or MDT?
Medtronic (MDT) is larger, with a market cap of $122.0B versus $66.2B for Boston Scientific, about 1.8 times the size.
Is BSX or MDT cheaper?
On trailing earnings, BSX is cheaper at 18.5x versus 23.4x for MDT. A lower P/E can reflect slower expected growth, so compare growth and margins too.
Which stock performed better over the past year, BSX or MDT?
MDT returned +4.6% over the past year including dividends, versus -55.4% for BSX, through October 23, 2026.
Which pays a higher dividend, BSX or MDT?
MDT yields 3.02%; BSX does not pay a dividend.
Full pages: Boston Scientific · Medtronic